Drug Shortage Report for MYLAN-INDAPAMIDE
| Report ID | 230100 |
| Drug Identification Number | 02240067 |
| Brand name | MYLAN-INDAPAMIDE |
| Common or Proper name | INDAPAMIDE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | INDAPAMIDE |
| Strength(s) | 1.25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100BT |
| ATC code | C03BA |
| ATC description | LOW-CEILING DIURETICS, EXCL THIAZIDES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-06-25 |
| Actual start date | 2024-06-28 |
| Estimated end date | Unknown |
| Actual end date | 2024-07-04 |
| Shortage status | Resolved |
| Updated date | 2024-07-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2024-07-09 | French | Compare |
| v9 | 2024-07-09 | English | Compare |
| v8 | 2024-07-03 | French | Compare |
| v7 | 2024-07-03 | English | Compare |
| v6 | 2024-06-26 | English | Compare |
| v5 | 2024-06-25 | French | Compare |
| v4 | 2024-06-25 | English | Compare |
| v3 | 2024-06-20 | English | Compare |
| v2 | 2024-06-11 | French | Compare |
| v1 | 2024-06-11 | English | Compare |
Showing 1 to 10 of 10